Skip to main content
NIH funding notice RFA-AI-21-012

Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)

Closed on August 4, 2021.

Posted
March 31, 2021
Close date
August 4, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,121,173 in first-year total cost, median $715,479.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 PP-A (J1)]3

Most frequent institutions

  1. CASE WESTERN RESERVE UNIVERSITY1
  2. SOUTHERN ILLINOIS UNIVERSITY CARBONDALE1
  3. UNIVERSITY OF IOWA1
Competing awards under RFA-AI-21-012 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development1R61AI169659-01WU, LIUNIVERSITY OF IOWA, IA$751,338ZAI1
2022The role of RNA m6A modification in the regulation of HIV latency and reactivation1R61AI169629-01KARN, JONATHANCASE WESTERN RESERVE UNIVERSITY, OH$715,479ZAI1
2022Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection1R61AI169661-01GAGNON, KEITH THOMASSOUTHERN ILLINOIS UNIVERSITY CARBONDALE, IL$654,356ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-21-012: Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) | ScienceDex | ConductScience